You are viewing the site in preview mode
Skip to main content
|
Variables
|
LAT/SEC group (n = 87)
|
Non-LAT/SEC group (n = 1071)
|
P
|
|---|
|
Age (years)
|
61.47 ± 10.78
|
56.54 ± 12.30
|
<0.001*
|
|
Female, n (%)
|
38 (43.68)
|
351 (32.77)
|
0.045*
|
|
Non-paroxysmal AF, n (%)
|
38 (43.68)
|
175 (16.34)
|
<0.001*
|
|
Type 2 diabetes mellitus, n (%)
|
31 (36.63)
|
148 (13.82)
|
<0.001*
|
|
Hypertension, n (%)
|
61 (70.11)
|
455 (42.48)
|
<0.001*
|
|
Stroke/TIA, n (%)
|
9 (10.34%)
|
19 (1.77)
|
<0.001*
|
|
Heart failure, n (%)
|
27 (31.03)
|
129 (12.04)
|
<0.001*
|
|
Vascular disease, N (%)
|
17 (19.54)
|
71 (6.63)
|
<0.001*
|
|
COPD, N (%)
|
21 (18.27)
|
211 (19.70)
|
0.855
|
|
Age ≥65, N (%)
|
38 (43.68)
|
310 (28.94)
|
0.005*
|
|
Age ≥75, N (%)
|
6 (6.90)
|
46 (4.30)
|
0.275
|
|
LVDd, (mm)
|
46.79 ± 4.67
|
45.84 ± 4.54
|
0.070
|
|
LAd, (mm)
|
41.36 ± 5.58
|
36.29 ± 5.66
|
<0.001*
|
|
LVEF, (%)
|
63.86 ± 6.89
|
65.79 ± 7.02
|
0.014*
|
|
Uric acid, (μmol/L)
|
395.98 ± 99.68
|
356.49 ± 78.04
|
<0.001*
|
|
Hb1Ac, (%)
|
6.13 ± 0.41
|
5.89 ± 0.45
|
<0.001*
|
|
LDL-C, (μmol/L)
|
3.06 ± 0.93
|
2.90 ± 0.81
|
0.336
|
|
D-dimer, (μg/L)
|
220.45 ± 210.42
|
247.87 ± 439.71
|
0.412
|
|
CHADS2 score
|
1.64 ± 1.27
|
0.76 ± 0.66
|
<0.001*
|
|
CHA2DS2-VASc score
|
2.71 ± 1.68
|
1.45 ± 1.30
|
<0.001*
|
-
AF atrial fibrillation, TIA: transient ischemic attack, LVDd left ventricular diastolic dimension, LAd left atrial dimension, LVEF left ventricular ejection fraction, LDL low-density lipoprotein, COPD chronic obstructive pulmonary disease
- * With statistical significance
